Generic name: CALCIPOTRIENE HYDRATE 50ug in 1g, BETAMETHASONE DIPROPIONATE 0.5mg in 1g
Dosage form: aerosol, foam
Medically reviewed on September 21, 2017.
Instruct patients to shake can prior to using Enstilar® Foam and to wash their hands after applying the product.
Apply Enstilar® Foam to affected areas once daily for up to 4 weeks. Rub in Enstilar® Foam gently. Discontinue use when control is achieved.
Instruct patients not to use more than 60 g every 4 days.
Enstilar® Foam should not be used with occlusive dressings unless directed by a physician. Enstilar® Foam is not for oral, ophthalmic, or intravaginal use.
Avoid use on the face, groin, or axillae, or if skin atrophy is present at the treatment site.
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.
More about Enstilar (betamethasone / calcipotriene topical)
- Enstilar Side Effects
- During Pregnancy
- Dosage Information
- Drug Interactions
- Support Group
- Pricing & Coupons
- En Español
- 6 Reviews – Add your own review/rating
- Drug class: topical antipsoriatics